These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7687638)

  • 1. Immortalization of antigen selected B cells.
    Steenbakkers PG; van Wezenbeek PM; Olijve W
    J Immunol Methods; 1993 Jul; 163(1):33-40. PubMed ID: 7687638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient generation of human anti-cytomegalovirus IgG monoclonal antibodies from preselected antigen-specific B cells.
    Steenbakkers PG; Van Wezenbeek PM; van Zanten J; The TH
    Hum Antibodies Hybridomas; 1993 Oct; 4(4):166-73. PubMed ID: 7504956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new approach to the generation of human or murine antibody producing hybridomas.
    Steenbakkers PG; van Meel FC; Olijve W
    J Immunol Methods; 1992 Jul; 152(1):69-77. PubMed ID: 1640111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and functional activity of isotype and subclass switched human monoclonal antibody reactive with the base of the V3 loop of HIV-1 gp120.
    Liu F; Bergami PL; Duval M; Kuhrt D; Posner M; Cavacini L
    AIDS Res Hum Retroviruses; 2003 Jul; 19(7):597-607. PubMed ID: 12908937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of IgG-producing hybridomas by in vitro stimulation of murine spleen cells.
    Takahashi M; Fuller SA; Hurrell JG
    J Immunol Methods; 1987 Feb; 96(2):247-53. PubMed ID: 3492563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization.
    Buchacher A; Predl R; Strutzenberger K; Steinfellner W; Trkola A; Purtscher M; Gruber G; Tauer C; Steindl F; Jungbauer A
    AIDS Res Hum Retroviruses; 1994 Apr; 10(4):359-69. PubMed ID: 7520721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mimicking the humoral immune response in vitro results in antigen-specific isotype switching supported by specific autologous T helper cells: generation of human HIV-1-neutralizing IgG monoclonal antibodies from naive donors.
    Chin LT; Malmborg AC; Kristensson K; Hinkula J; Wahren B; Borrebaeck CA
    Eur J Immunol; 1995 Mar; 25(3):657-63. PubMed ID: 7535699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of murine monoclonal antibodies directed against the submembrane protein p17 of HIV-1.
    Niedrig M; Harthus HP; Bröker M; Meloen R; Gelderblom H; Pauli G
    Hybridoma; 1993 Aug; 12(4):431-9. PubMed ID: 7503941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requirements for the generation of memory B cells in vivo and their subsequent activation in vitro for the production of antigen-specific hybridomas.
    De Boer M; Ten Voorde GH; Ossendorp FA; Van Duijn G; Tager JM
    J Immunol Methods; 1988 Oct; 113(1):143-9. PubMed ID: 2459251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro stimulation of immune spleen cells enhances the number of anti-lipid A-producing hybridomas.
    Erich T; Dekker B; De Beer M; Torensma R; Verhoef J
    J Immunol Methods; 1989 Mar; 118(1):17-24. PubMed ID: 2647854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epitopes of the HIV-1-negative factor (nef) reactive with murine monoclonal antibodies and human HIV-1-positive sera.
    Schneider T; Harthus HP; Hildebrandt P; Niedrig M; Bröker M; Weigelt W; Beck A; Pauli G
    AIDS Res Hum Retroviruses; 1991 Jan; 7(1):37-44. PubMed ID: 1707640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of I region-restricted, antigen-specific T cell hybridomas to produce idiotypically specific anti-receptor antibodies.
    White J; Haskins KM; Marrack P; Kappler J
    J Immunol; 1983 Mar; 130(3):1033-7. PubMed ID: 6185566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of HIV-1 gp120 to an anti-V3 loop antibody reveals novel antigen-induced epitopes.
    Denisova G; Zwickel J; Gershoni JM
    FASEB J; 1995 Jan; 9(1):127-32. PubMed ID: 7529735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new and rapid method for the selection and cloning of antigen-specific hybridomas with magnetic microspheres.
    Horton JK; Evans OM; Swann K; Swinburne S
    J Immunol Methods; 1989 Nov; 124(2):225-30. PubMed ID: 2480979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro B-lymphocyte antigen priming against both non-immunogenic and immunogenic molecules requiring low amounts of antigen and applicable in hybridoma technology.
    Brams P; Pettijohn DE; Brown M; Olsson L
    J Immunol Methods; 1987 Apr; 98(1):11-22. PubMed ID: 2435806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV Broadly Neutralizing Antibodies: VRC01 and Beyond.
    Wu X
    Adv Exp Med Biol; 2018; 1075():53-72. PubMed ID: 30030789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of anti-tumor human monoclonal antibodies using different approaches.
    Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
    Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Monoclonal antibodies from the hybridization of lymphocytes].
    Ax W
    Ric Clin Lab; 1983; 13 Suppl 2():1-9. PubMed ID: 6366991
    [No Abstract]   [Full Text] [Related]  

  • 19. HIV antibodies and vaccine design.
    Bolognesi DP
    AIDS; 1989; 3 Suppl 1():S111-8. PubMed ID: 2482052
    [No Abstract]   [Full Text] [Related]  

  • 20. An attempt to produce "pre-T" cell hybridomas and to identify their antigens.
    Aihara Y; Bühring HJ; Aihara M; Klein J
    Eur J Immunol; 1986 Nov; 16(11):1391-9. PubMed ID: 3096743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.